Gastrointestinal

DELANZO

Dexlansoprazole 30 mg & 60 mg

Dosage formCapsule
Pack size3 X 10's
DELANZO packaging
Product information

Details

Composition

DELANZO 30 Capsule: Each capsule contains Dexlansoprazole INN 30mg as enteric coated pellets,

DELANZO 60 Capsule: Each capsule contains Dexlansoprazole INN 60mg as enteric coated pellets

Description

DELANZO (Dexlansoprazole) delayed release capsule has been characterized as a gastric Proton Pump Inhibitor (PP) that blocks the final step of gastric acid production, It is the R-enantiomer of Lansoprazole ja racemic mixture of the R- and S-enantiomers). Dexlansoprazole capsule contains enteric coated pellets with different pH-dependent dissolution profiles.

The formulation of DELANZO (Dexlansoprazole) utilizes Dual Delayed Release (DDR) technology which results in plasma concentration-time profile with two distinct peaks; the first peak occurs within 1 to 2 hours after administration, followed by a second peak within 4 to 5 hours. No accumulation of Dexlansoprazole occurs after multiple daily doses of DELANZO 30 mg or 60 mg.

Indications

DELANZO Dexlansoprazole) is a Proton Pump Inhibitor (PPI) used to treat-

1. Healing of all grades of Erosive Esophagitis

2. Maintenance of healed Erosive Esophagitis

3. Heartburn associated with Non-Erosive Gastroesophageal reflux disease (GERD)

Dosage & Administration

DELANZO (Dexlansoprazole) capsule is administered orally. The recommended doses of Dexlansoprazole for adults are as follows:

 

IndicationDose
Healing of Erosive Esophagitis60 mg once daily for up to 8 weeks
Maintenance of healed Erosive Esophagitis and relief of heartburn30 mg once daily for up to 6 months
Symptomatic Non-Erosive GERD30 mg once daily for up to 4 weeks

Contraindications

Dexlansoprazole is contraindicated in patients with known hypersensitivity to any component of the formulation.

Warnings & Precautions

Patients taking concomitant Warfarin may require monitoring for increased International Normalized Ratio (INF) and Prothrombin Time, Increased INR and Prothrombin Time may lead to abnormal bleeding and even death.

Overdose

There have been no reports of significant overdose of Dexlanzoprazole, Multiple doses of Dexlansoprazole 120 mg and a single dose of Dexlansoprazole 300 mg did not result in any severe adverse events.

Storage Conditions

Store below 30 C & in dry places. Protect from light. Keep out of the reach of children

Commercial Pack

DELANZO 30 Capsule: Each box contains 30 capsules in 5 x 10's Alu-Alu blister strips

DELANZO 60 Capsule: Each box contains 30 capsules in 3 x 10's Allu-Alu blister strips